Sonida Senior Living ROE 2010-2024 | SNDA

Current and historical return on equity (ROE) values for Sonida Senior Living (SNDA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Sonida Senior Living ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.02B $0.09B 60.95%
2024-06-30 $-0.02B $-0.03B 28.57%
2024-03-31 $-0.02B $-0.04B 26.21%
2023-12-31 $-0.03B $-0.12B 26.80%
2023-09-30 $-0.03B $-0.10B 29.87%
2023-06-30 $-0.02B $-0.09B 25.84%
2023-03-31 $-0.02B $-0.08B 22.75%
2022-12-31 $-0.06B $-0.10B 71.47%
2022-09-30 $-0.06B $-0.09B 83.33%
2022-06-30 $-0.00B $-0.07B 3.60%
2022-03-31 $0.06B $-0.06B -48.35%
2021-12-31 $0.11B $-0.05B -70.89%
2021-09-30 $0.11B $-0.15B -48.61%
2021-06-30 $-0.15B $-0.19B 60.68%
2021-03-31 $-0.21B $-0.24B 101.70%
2020-12-31 $-0.30B $-0.28B 192.18%
2020-09-30 $-0.27B $-0.26B 330.22%
2020-06-30 $-0.07B $-0.04B 481.36%
2020-03-31 $-0.07B $-0.03B -3550.00%
2019-12-31 $-0.04B $0.01B -200.00%
2019-09-30 $-0.07B $0.00B -307.37%
2019-06-30 $-0.06B $0.02B -165.79%
2019-03-31 $-0.06B $0.03B -119.19%
2018-12-31 $-0.05B $0.04B -88.70%
2018-09-30 $-0.03B $0.06B -46.48%
2018-06-30 $-0.03B $0.07B -38.83%
2018-03-31 $-0.03B $0.08B -35.05%
2017-12-31 $-0.04B $0.08B -49.86%
2017-09-30 $-0.05B $0.09B -50.26%
2017-06-30 $-0.05B $0.09B -44.86%
2017-03-31 $-0.04B $0.10B -37.85%
2016-12-31 $-0.03B $0.12B -22.49%
2016-09-30 $-0.02B $0.12B -17.79%
2016-06-30 $-0.01B $0.13B -9.74%
2016-03-31 $-0.01B $0.13B -10.35%
2015-12-31 $-0.01B $0.14B -10.22%
2015-09-30 $-0.01B $0.14B -8.68%
2015-06-30 $-0.02B $0.14B -15.11%
2015-03-31 $-0.03B $0.14B -18.28%
2014-12-31 $-0.03B $0.14B -17.04%
2014-09-30 $-0.02B $0.14B -15.23%
2014-06-30 $-0.03B $0.15B -17.42%
2014-03-31 $-0.02B $0.16B -11.88%
2013-12-31 $-0.02B $0.16B -9.80%
2013-09-30 $-0.02B $0.16B -9.64%
2013-06-30 $-0.01B $0.17B -4.15%
2013-03-31 $-0.01B $0.17B -3.55%
2012-12-31 $-0.00B $0.17B -2.36%
2012-09-30 $-0.00B $0.17B -1.18%
2012-06-30 $0.00B $0.17B 0.00%
2012-03-31 $0.00B $0.17B 1.18%
2011-12-31 $0.00B $0.17B 1.78%
2011-09-30 $0.01B $0.17B 2.99%
2011-06-30 $0.00B $0.17B 2.42%
2011-03-31 $0.00B $0.17B 2.45%
2010-12-31 $0.00B $0.16B 2.47%
2010-09-30 $0.00B $0.16B 1.87%
2010-06-30 $0.00B $0.16B 2.52%
2010-03-31 $0.00B $0.16B 1.90%
2009-12-31 $0.00B $0.16B 1.92%
Sector Industry Market Cap Revenue
Medical Medical Services $0.441B $0.255B
Sonida Senior Living is an owner-operator of senior living communities and services. Sonida Senior Living, formerly known as Capital Senior Living Corporation, is based in DALLAS.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00